Evidence themes guiding FDA decisions

Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content:

• The US Food and Drug Administration's Regulation of Mifepristone
• Politics, Science, and the Future of FDA Drug Regulation